H.P. Acthar Gel (repository corticotropin injection) treatment of patients with multiple sclerosis and diabetes.

Authors:
Kutz C.

Journal:
Ther Adv Chronic Dis

Publication Year: 2016

DOI:
10.1177/2040622316644481

PMCID:
PMC4935834

PMID:
27433309

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Ther Adv Chronic Dis

Abbreviation: Ther Adv Chronic Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Aortic arch calcification increases major adverse cardiac event risk, modifiable by echocardiograph…
Chao CT; Liao MT; Wu CK. (2024) - Transparency Score: 3/6
Clinical and imaging findings in enteropathic spondyloarthritis with special emphasize in diagnosti…
Conigliaro P; D'Antonio A; Wlderk A and 7 more (2024) - Transparency Score: 3/6
Epidemiological characteristics, etiological spectrum, and outcomes of adult patients with pericard…
Farah Yusuf Mohamud M; Abdi IA; Uzel M and 5 more (2024) - Transparency Score: 3/6
Photodynamic therapy of cervical cancer: a scoping review on the efficacy of various molecules.
Shanazarov NA; Zare A; Mussin NM and 5 more (2024) - Transparency Score: 3/6
Prevalence of major non-communicable diseases and their associated risk factors in Afghanistan: a s…
Noormal AS; Winkler V; Bhusari SB and 8 more (2024) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest statement: The author is a speaker for Mallinckrodt."

Evidence found in paper:

"Funding: Funding to support the preparation of this manuscript was provided by Mallinckrodt ARD Inc. (formerly known as Questcor Pharmaceuticals) to MedVal Scientific Information Services, LLC (Skillman, NJ, USA)."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025